It’s always been normal to notice when something inside goes off track - like chemicals drifting, signals slowing, balance tipping. When a thyroid slows down, doctors fix it; nobody argues. If the pancreas stops managing blood sugar, treatment follows, no hesitation. Even ovaries shutting down early get help. The same help is causing uproar today. Hormones, once quietly given, now stir noise. Each time, doctors step in where the body falls short, offering help without demanding proof of pain. Though the struggle differs, when it comes to mismatched gender and flesh, doubt creeps in fast. Real discomfort sits there, clear in scans and symptoms, backed by research like any illness. Still, those seeking relief face questions far beyond a diagnosis. They’re made to defend who they are, how deeply they feel it, and whether they deserve aid at all. The treatments stay rooted in data, unchanged from before. Just the hands reaching for them draw more scrutiny than ever.
Gender dysphoria is a clinically recognised condition, defined in both the DSM-5 and ICD-11. It is a state of mind in which a person experiences significant distress due to a mismatch between their gender identity (i.e. what they feel they are) and their assigned sex at birth. And here is the important part of the definition: it is the word “distress”, not gender identity confusion, not going through a phase, not a social movement. Gender dysphoria refers to the specific quantity of suffering and well-documented effects on cognition and mental health. One final thing to remember, gender dysphoria is not the same as being transgender. Not every transgender person experiences significant gender dysphoria, and it is never appropriate to force any person into gender-affirming treatments if they choose not to.
Once we prove the clinical reality of gender dysphoria, the evidence is almost unassailable and points towards a single approach to managing it. The science behind gender affirming care has been built up over decades of research in the clinic, which has gone through the normal process of multiple reviews by peers, and has been endorsed by the World Health Organisation, the American Medical Association, and the World Professional Association for Transgender Health (WPATH). The fact that there is apparently room for “debate” about the management of gender dysphoria has nothing to do with the science underlying the approach that has been supported by the evidence, and everything to do with the fact that there is currently a large disconnect between the actual evidence being generated in the clinic and the information that is actually reaching the public. And in between, there is usually a whole lot of fear, politics and misinformation. Managing gender dysphoria as a clinical condition is one thing. Managing the misinformation about gender dysphoria and the trans community as it is generated in the public and media domain is quite another. And this also requires a different conversation.
Hormone Replacement Therapy (HRT) isn’t unique to trans people, and in fact is a well-established medical treatment for a variety of medical conditions. For example, post menopausal women having osteoporosis, men with low testosterone levels and people who have had thyroid surgery all need hormone replacement therapy. The hormones are the same as for transgender people and have the same biological effects and side effects.
Within the context of gender-affirming care, HRT takes two main forms:
Hormones take months to years to have an effect. They are not something that you can start today and notice a change tomorrow. Some of the effects of hormones can be reversible if you stop taking them, like weight gain, changes in fertility, etc. Others, like a deepening voice or breasts developing, are not reversible. So we make sure to explain all of these changes before we begin any therapy.
Safety: Most risks tied to hormone therapy come from using it without a doctor. That fact shows up clearly in a 2017 study from the Journal of Clinical Endocrinology & Metabolism. When care includes proper medical oversight, treatment turns out safe. Problems usually pop up only when people adjust doses on their own. Risks are real but manageable:
Beyond general health, these treatments tend to hold up well over time. Their safety matches that of familiar hormone options used across clinics today. Though rare, side effects do happen - just like with any similar medical approach. Most people tolerate them without serious issues. Long-term tracking shows stability when monitored properly. Risk levels stay low if guidelines are followed closely. Some hesitation remains among specialists despite broad acceptance. Real-world data support continued use under supervision. Not everybody reacts the same way. Still, patterns point toward consistent outcomes overall.
Gender-affirmation therapy, also known as Gender Identity (GI) therapy, is a type of talk therapy. It is not a quick pathway to get hormones. Gender-affirmation therapy is a therapeutic approach to helping individuals who may be struggling with their gender identity to explore, process and understand their gender-related distress. Additionally, to help individuals consider their options and make informed choices, including the choice not to medically transition. The mental health outcomes of gender-affirming care are among the most consistently replicated findings in the field of medicine. Studies from many countries and populations worldwide have shown:
However, Conversion therapy — trying to alter the gender identity of someone — is a very different intervention and has been widely condemned, banned, or heavily restricted in many countries around the world due to the extensive research on the harm caused to participants.
Gender affirming care in India exists in a legal and medical limbo. While India’s 2019 Transgender Persons (Protection of Rights) Act formally recognises transgender identity, there is an acute lack of safe, supervised provision of Hormone Replacement Therapy (HRT). A small number of endocrinologists who specialise in transgender care are based in major cities, leaving the majority of people to self-medicate by buying hormones from a pharmacy. Self-medication is the main reason for people having adverse reactions to hormones.
Thyroid hormone replacement or Hormone Replacement Therapy (HRT) is one of the most prescribed medications in the country and is administered to millions across India, in its most basic form, without a second thought or debate. The drug, as is the case with many other forms of HRT, replaces a hormone that is either nonexistent or inadequate in the human body and brings back balance at the cellular and mental levels.
The clinical gap is therefore not a scientific gap. It is a gap of access, capacity and acceptance.
Bottom Line
HRT and gender-affirming care do not change who people are.
They reduce biological and psychological suffering and help people live healthier, more stable lives.
REFERENCES